시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 충수암 치료 시장 보고서(2025년)
Appendiceal Cancer Treatment Global Market Report 2025
상품코드 : 1824580
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,661,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,629,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,596,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

세계의 충수암 치료 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년까지 CAGR 5.2%로 확대되어 51억 1,000만 달러로 성장할 것으로 예상됩니다. 예측기간의 성장은 면역요법의 진보, 표적요법, 유전체의료, 규제당국의 승인, 환자 중심의 의료에 기인하고 있습니다. 예측 기간의 주요 동향에는 면역 요법의 진보, 정밀의료 및 바이오 마커 식별, 병용 요법, 디지털 건강 기술, 실제 세계 증거, 데이터 중심의 의사 결정 등이 포함됩니다.

향후 5년간의 성장률 5.2%라는 예측은 지난 예측으로부터 0.1% 소폭 감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 관세 인상은 프랑스와 이탈리아에서 조달하는 HIPEC(복강내 고열 화학요법) 시스템이나 세포 감퇴 수술 기구의 가격을 밀어 올리고, 희소암 치료비를 악화시켜, 전문 시설의 능력을 제한함으로써, 미국의 외과 종양학에 부담을 줄 가능성이 높습니다. 또한 상호 관세와 무역 긴장 증가와 제한으로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향이 더 광범위하게 가해질 수 있습니다.

임상 검사 증가가 예상되기 때문에 충수암 치료 시장의 향후 성장이 기대됩니다. 임상검사는 인간이 참여하는 향후의 조사연구이며, 충수암에 대한 생물의료적 또는 행동학적 개입을 조사 및 비교하는데 중요한 역할을 합니다. 이러한 임상 검사는 질병에 대한 이해를 깊게 하고 보다 적은 효과적인 접근법을 통해 치료 옵션을 늘리는 데 크게 기여합니다. Xtalks의 보고서에 따르면 2023년 5월 현재 ClinicalTrials.gov에 등록된 임상 검사는 전 세계 45만 2,604건으로 6만 4,838명이 참가자를 모집 중입니다. 이는 2021년 초에 보고된 36만 5,000건이 넘는 등록검사로부터 현저한 증가를 나타내며, 이로써 충수암 시장의 성장을 가속하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 전략

제36장 부록

JHS
영문 목차

영문목차

Treatment for appendiceal cancer involves employing medical interventions and therapies to effectively manage and address cancer originating in the appendix, a small organ attached to the beginning of the large intestine. This is crucial for handling this rare type of cancer and enhancing the prognosis and quality of life for affected individuals.

The primary modalities for treating appendiceal cancer encompass colonic-type adenocarcinoma, mucinous adenocarcinoma of the appendix, goblet cell adenocarcinoma, neuroendocrine carcinoma, and other variants. Colonic-type adenocarcinoma specifically denotes a type of cancer that emerges within the epithelial cells, constituting the linings of both internal and external body surfaces. Treatment options include surgical procedures, chemotherapy, radiation therapy, and other modalities, which can be administered orally, intravenously, or through other means. The end-users of these treatments are hospitals, cancer research institutes, and other relevant institutions.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The appendiceal cancer treatment market research report is one of a series of new reports from The Business Research Company that provides appendiceal cancer treatment market statistics, including appendiceal cancer treatment industry global market size, regional shares, competitors with an appendiceal cancer treatment market share, detailed appendiceal cancer treatment market segments, market trends and opportunities, and any further data you may need to thrive in the appendiceal cancer treatment industry. This appendiceal cancer treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The appendiceal cancer treatment market size has grown steadily in recent years. It will grow from $3.98 billion in 2024 to $4.17 billion in 2025 at a compound annual growth rate (CAGR) of 4.6%. The growth in the historic period can be attributed to clinical research and trials, diagnostic improvements, collaboration and multidisciplinary approaches, government initiatives and funding, awareness and education.

The appendiceal cancer treatment market size is expected to see strong growth in the next few years. It will grow to $5.11 billion in 2029 at a compound annual growth rate (CAGR) of 5.2%. The growth in the forecast period can be attributed to immunotherapy advances, targeted therapies, genomic medicine, regulatory approvals, patient-centric care. Major trends in the forecast period include immunotherapy advancements, precision medicine and biomarker identification, combination therapies, digital health technologies, real-world evidence and data-driven decision making.

The forecast of 5.2% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. surgical oncology by driving up the cost of HIPEC (hyperthermic intraperitoneal chemotherapy) systems and cytoreductive surgery instruments sourced from France and Italy, exacerbating rare cancer treatment costs and limiting specialized center capabilities. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The anticipated rise in clinical trials is expected to drive the growth of the appendiceal cancer treatment market in the future. Clinical trials, which are upcoming research studies involving human participants, play a crucial role in investigating and comparing biomedical or behavioral interventions for appendiceal cancer. These trials contribute significantly to advancing our understanding of the disease and enhancing treatment options through more targeted and effective approaches. As of May 2023, a report from Xtalks indicates that there are currently 452,604 registered clinical trials worldwide on ClinicalTrials.gov, with 64,838 actively recruiting participants. This represents a notable increase from the reported over 365,000 registered trials in early 2021, thereby propelling the growth of the appendiceal cancer market.

The increasing healthcare expenditure is expected to drive the growth of the appendiceal cancer treatment market in the future. Healthcare expenditure refers to the total amount of money spent on healthcare-related goods and services, encompassing costs associated with diagnosing, managing, and treating conditions like appendiceal cancer. This spending includes medical services, therapies, and support systems for patients, contributing to advancements in treatment options and healthcare infrastructure. For example, in May 2023, a report from the Office for National Statistics, a UK-based government department, showed that healthcare spending in the UK grew by 5.6% between 2022 and 2023, compared to a growth of just 0.9% in 2022. The total healthcare expenditure in the UK was approximately $317.63 billion (£292 billion) in 2023. As healthcare budgets continue to rise globally, particularly in the area of cancer care, the appendiceal cancer treatment market is likely to expand, enabling better access to diagnosis and treatment for affected patients.

Key players in the appendiceal cancer treatment market are focused on developing cutting-edge technologies such as digital health solutions, AI-powered diagnostic tools, personalized treatment platforms, and telemedicine services to improve patient engagement and streamline the delivery of care. Digital health solutions refer to technologies that utilize digital tools to enhance healthcare, including telemedicine, mobile health applications, and remote patient monitoring systems. For example, in October 2024, CancerX, a US-based biotechnology and healthcare company, launched the 2025 Accelerator Program. The new cohort will place a specific emphasis on pediatric oncology, with two out of the fifteen available positions dedicated to startups focused on innovation in this field. This collaboration with KidsX aims to leverage the capabilities of over 30 pediatric hospitals to improve outcomes for young patients.

In June 2022, Truveta Inc., a US-based medical technology company, partnered with Pfizer Inc., a US-based pharmaceutical company, to enhance the discovery, monitoring, and assessment of possible signals using entire Electronic Medical Record data for over 50 million patients. This collaboration aims to advance medication development for the treatment of appendiceal cancer, with Pfizer Inc. utilizing its expertise in pharmaceuticals to contribute to the ongoing progress in this field.

Major companies operating in the appendiceal cancer treatment market report are Pfizer Inc., Roche Holding AG, F. Hoffman-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A, Bristol-Myers Squibb Company, Fresenius Kabi USA, Eli Lilly & Company, Boehringer Ingelheim International GmbH, Gilead Sciences Inc., Amgen Inc., Johnsons & Johnsons, Becton Dickinson and Company, GE HealthCare Technologies Inc., Teva Pharmaceutical Industries Ltd., AstraZeneca PLC, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Cipla Inc., Genetech Inc., Lupin Limited, Gland Pharma Limited, Accord Healthcare Limited, ImmunoGen Inc.

North America was the largest region in the appendiceal cancer treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the appendiceal cancer treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the appendiceal cancer treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The appendiceal cancer treatment market consists of revenues earned by entities by providing services such as diagnosis and staging services, appendectomy, hemicolectomy, medical oncology services, radiation oncology services, clinical trial services, multidisciplinary care coordination, palliative and supportive care services, and nutrition services. The market value includes the value of related goods sold by the service provider or included within the service offering. The appendiceal cancer treatment market also includes sales of avastin (bevacizumab), fluorouracil, leucovorin (folinic acid), capecitabine (Xeloda), irinotecan (Camptosar), and oxaliplatin (Eloxatin). Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Appendiceal Cancer Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on appendiceal cancer treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for appendiceal cancer treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The appendiceal cancer treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Appendiceal Cancer Treatment Market Characteristics

3. Appendiceal Cancer Treatment Market Trends And Strategies

4. Appendiceal Cancer Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Appendiceal Cancer Treatment Growth Analysis And Strategic Analysis Framework

6. Appendiceal Cancer Treatment Market Segmentation

7. Appendiceal Cancer Treatment Market Regional And Country Analysis

8. Asia-Pacific Appendiceal Cancer Treatment Market

9. China Appendiceal Cancer Treatment Market

10. India Appendiceal Cancer Treatment Market

11. Japan Appendiceal Cancer Treatment Market

12. Australia Appendiceal Cancer Treatment Market

13. Indonesia Appendiceal Cancer Treatment Market

14. South Korea Appendiceal Cancer Treatment Market

15. Western Europe Appendiceal Cancer Treatment Market

16. UK Appendiceal Cancer Treatment Market

17. Germany Appendiceal Cancer Treatment Market

18. France Appendiceal Cancer Treatment Market

19. Italy Appendiceal Cancer Treatment Market

20. Spain Appendiceal Cancer Treatment Market

21. Eastern Europe Appendiceal Cancer Treatment Market

22. Russia Appendiceal Cancer Treatment Market

23. North America Appendiceal Cancer Treatment Market

24. USA Appendiceal Cancer Treatment Market

25. Canada Appendiceal Cancer Treatment Market

26. South America Appendiceal Cancer Treatment Market

27. Brazil Appendiceal Cancer Treatment Market

28. Middle East Appendiceal Cancer Treatment Market

29. Africa Appendiceal Cancer Treatment Market

30. Appendiceal Cancer Treatment Market Competitive Landscape And Company Profiles

31. Appendiceal Cancer Treatment Market Other Major And Innovative Companies

32. Global Appendiceal Cancer Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Appendiceal Cancer Treatment Market

34. Recent Developments In The Appendiceal Cancer Treatment Market

35. Appendiceal Cancer Treatment Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기